▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3766 by analyst upside · 2026-09-29
BDX
Becton, Dickinson and Company
Healthcare · Market Cap $50B · P/E 31.9x
ANALYST PRICE TARGET
+6.4%
implied upside to consensus target
Current Price $183.83
Consensus Target $195.67
Bull Target $225.0
Bear Target $170.0
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
5
Hold
6
Sell
0
52-Week Low $127.59
52-Week High $193.07
YTD Return +22.3%
FUNDAMENTALS
Market Cap $50B
P/E Ratio (TTM) 31.9x
Forward P/E 13.8x
EPS (TTM) $5.77
PEG Ratio 1.11
Dividend Yield 2.28%
Revenue (TTM) $22.5B
Profit Margin 4.2%
52-WEEK RANGE
52-Week Low $127.59
52-Week High $193.07
Current Price $183.83
Bear Target $170.0
Bull Target $225.0
● Now $183.83 ● Target $195.67
TRADING DATA
Avg Volume 1.8M
YTD Return +22.3%
Analyst Count 12
Consensus Buy
Upside to Target +6.4%
Last Updated 2026-09-29

ANALYST SUMMARY

Becton, Dickinson and Company (BDX) is currently trading at $183.83 with a Wall Street consensus price target of $195.67, implying potential upside of 6.4% over the next 12 months. 12 analysts currently cover BDX, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $225.0, while the most cautious has a target of $170.0.

BDX operates in the Healthcare sector with a market capitalisation of $50B. The stock is up 22.3% year-to-date and is currently trading near the upper end of its 52-week range of $127.59 – $193.07.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CAH +22.7%
Cardinal Health, Inc.
$51B · P/E 30.5x · Buy
IQV +3.2%
IQVIA Holdings Inc.
$45B · P/E 33.7x · Buy
HUM +8.8%
Humana Inc.
$47B · P/E 36.8x · Buy
A +0.1%
Agilent Technologies, Inc.
$49B · P/E 34.2x · Buy
ARGX +20.8%
argenx SE
$60B · P/E 36.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for BDX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

B of A Securities - Reiterated
Neutral → Neutral 2026-08-31 Building track record
RBC Capital - Reiterated
Sector Perform → Sector Perform 2026-08-13 Building track record
Citigroup - Reiterated
Buy → Buy 2026-08-07 Building track record
RBC Capital - Reiterated
Sector Perform → Sector Perform 2026-08-07 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2026-08-07 14% win rate (7 calls)
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-08-07 Building track record
TD Cowen - Reiterated
Hold → Hold 2026-08-05 Building track record
UBS ● Initiated
Buy 2026-07-28 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
20/30
Consensus clarity
24/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →